跳至主要内容
临床试验/ISRCTN54006056
ISRCTN54006056进行中(未招募)3 期

PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the Emergency department.

niversity of Liverpool0 个研究点目标入组 7,676 人开始时间: 2019年12月19日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
7,676

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35697438/ (added 15/06/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients =16 years presenting to the ED with suspected sepsis

排除标准

  • 1. Currently on intravenous antibiotics
  • 2. Current use of any chemotherapy agent associated with myeloablation/suppression
  • 3. History of solid organ transplantation, allogeneic bone marrow or stem cell transplantation within 3 months prior to consent
  • 4. Patients known to require urgent surgical intervention (within the course of current admission)
  • 5. Presence of an advance directive to withhold life-sustaining treatment (patients not wishing to receive Cardiopulmonary Resuscitation (CPR) may qualify provided they receive all other resuscitative measures e.g. respiratory support, fluid resuscitation)

研究者

发起方
niversity of Liverpool

相似试验